The impact of neurobehavioral features on medication adherence in HIV: Evidence from longitudinal models

References

• Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto, P., … Antinori, A. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndromes, 31(Suppl. 3), S123–S127. doi:10.1097/00126334-200212153-00007
   PubMed Web of Science ®Google Scholar
• Applebaum, A. J., Richardson, M. A., Brady, S. M., Brief, D. J., & Keane, T. M. (2009). Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder. AIDS and Behavior, 13(1), 60–65. doi:10.1007/s10461-008-9441-x
   PubMed Web of Science ®Google Scholar
• Barclay, T. R., Hinkin, C. H., Castellon, S. A., Mason, K. I., Reinhard, M. J., Marion, S. D., … Durvasula, R. S. (2007). Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychology, 26(1), 40–49. doi:10.1037/0278-6133.26.1.40
   PubMed Web of Science ®Google Scholar
• Bates, D., & Maechler, M. (2010). lme4: Linear mixed-effects models using S4 classes. R package version 0.999375-37. Retrieved from http://cran.r-project.org/web/packages/lme4/index.html
   Google Scholar
• Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck depression inventory manual (2nd ed.). San Antonio, TX: Psychological Corporation.
   Google Scholar
• Becker, S. L., Dezii, C. M., Burtcel, B., Kawabata, H., & Hodder, S. (2002). Young HIV-infected adults are at greater risk for medication nonadherence. Medscape General Medicine, 4(3), 21.
   PubMedGoogle Scholar
• Beer, L., Heffelfinger, J., Frazier, E., Mattson, C., Roter, B., Barash, E., … Valverde, E. (2012). Use of and adherence to antiretroviral therapy in a large U.S. sample of HIV-infected adults in care, 2007–2008. Open AIDS Journal, 6, 213–223. doi:10.2174/1874613601206010213
   PubMedGoogle Scholar
• Bottonari, K. A., Tripathi, S. P., Fortney, J. C., Curran, G., Rimland, D., Rodriguez-Barradas, M., … Pyne, J. M. (2012). Correlates of antiretroviral and antidepressant adherence among depressed HIV-infected patients. AIDS Patient Care STDS, 26(5), 265–273. doi:10.1089/apc.2011.0218
   PubMed Web of Science ®Google Scholar
• Castellon, S. A., Hinkin, C. H., & Myers, H. F. (2000). Neuropsychiatric disturbance is associated with executive dysfunction in HIV-1 infection. Journal of the International Neuropsychological Society, 6(3), 336–347. doi:10.1017/S1355617700633088
   PubMed Web of Science ®Google Scholar
• Castellon, S. A., Hinkin, C. H., Wood, S., & Yarema, K. T. (1998). Apathy, depression, and cognitive performance in HIV-1 infection. Journal of Neuropsychiatry & Clinical Neurosciences, 10(3), 320–329.
   PubMed Web of Science ®Google Scholar
• Cha, E., Erlen, J. A., Kim, K. H., Sereika, S. M., & Caruthers, D. (2008). Mediating roles of medication-taking self-efficacy and depressive symptoms on self-reported medication adherence in persons with HIV: A questionnaire survey. International Journal of Nursing Studies, 45(8), 1175–1184. doi:10.1016/j.ijnurstu.2007.08.003
   PubMed Web of Science ®Google Scholar
• Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., & Wu, A. W. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. patient care committee & adherence working group of the outcomes committee of the adult AIDS clinical trials group (AACTG). AIDS Care, 12, 255–266. doi:10.1080/09540120050042891
   PubMed Web of Science ®Google Scholar
• Cole, M. A., Castellon, S. A., Perkins, A. C., Ureno, O. S., Robinet, M. B., Reinhard, M. J., … Hinkin, C. H. (2007). Relationship between psychiatric status and frontal-subcortical systems in HIV-infected individuals. Journal of the International Neuropsychological Society, 13(3), 549–554. doi:10.1017/S135561770707066X
   PubMed Web of Science ®Google Scholar
• Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994). The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia. Neurology, 44(12), 2308–2314. doi:10.1212/WNL.44.12.2308
   PubMed Web of Science ®Google Scholar
• Deeks, E. D., & Perry, C. M. (2010). Efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Atripla®): A review of its use in the management of HIV infection. Drugs, 70(17), 2315–2338. doi:10.2165/11203800-000000000-00000
   PubMed Web of Science ®Google Scholar
• Del Re, A. C. (2010). Compute.es: Computer effect sizes (Version R Package version 0.2). Retrieved from: http://www.R-project.org
   Google Scholar
• Ettenhofer, M. L., Foley, J., Castellon, S. A., & Hinkin, C. H. (2010). Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology, 74(15), 1217–1222. doi:10.1212/WNL.0b013e3181d8c1ca
   PubMed Web of Science ®Google Scholar
• Gorman, A. A., Foley, J. M., Ettenhofer, M. L., Hinkin, C. H., & van Gorp, W. G. (2009). Functional consequences of HIV-associated neuropsychological impairment. Neuropsychology Review, 19(2), 186–203. doi:10.1007/s11065-009-9095-0
   PubMed Web of Science ®Google Scholar
• Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., … Longshore, D. (2007). Drug use and medication adherence among HIV-1 infected individuals. AIDS and Behavior, 11(2), 185–194. doi:10.1007/s10461-006-9152-0
   PubMed Web of Science ®Google Scholar
• Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., … Stefaniak, M. (2002). Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology, 59(12), 1944–1950. doi:10.1212/01.WNL.0000038347.48137.67
   PubMed Web of Science ®Google Scholar
• Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., & Stefaniak, M. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS, 18(Suppl. 1), S19–25. doi:10.1097/00002030-200401001-00004
   PubMed Web of Science ®Google Scholar
• Ickovics, J. R., & Meisler, A. W. (1997). Adherence in AIDS clinical trials: A framework for clinical research and clinical care. Journal of Clinical Epidemiology, 50(4), 385–391. doi:10.1016/S0895-4356(97)00041-3
   PubMed Web of Science ®Google Scholar
• Johnson, M. O., Chesney, M. A., Goldstein, R. B., Remien, R. H., Catz, S., Gore-Felton, C., … Morin, S. F. (2006). Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model. AIDS Patient Care and STDs, 20(4), 258–268. doi:10.1089/apc.2006.20.258
   PubMed Web of Science ®Google Scholar
• Kalichman, S. C., Ramachandran, B., & Catz, S. (1999). Adherence to combination antiretroviral therapies in HIV patients of low health literacy. Journal of General Internal Medicine, 14(5), 267–273. doi:10.1046/j.1525-1497.1999.00334.x
   PubMed Web of Science ®Google Scholar
• Kamat, R., Woods, S. P., Marcotte, T. D., Ellis, R. J., & Grant, I. (2012). Implications of apathy for everyday functioning outcomes in persons living with HIV infection. Archives of Clinical Neuropsychology, 27(5), 520–531. doi:10.1093/arclin/acs055
   PubMed Web of Science ®Google Scholar
• Litvan, I., Paulsen, J. S., Mega, M. S., & Cummings, J. L. (1998). Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Archives of Neurology, 55(10), 1313–1319. doi:10.1001/archneur.55.10.1313
   PubMed Web of Science ®Google Scholar
• Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., … Wenger, N. S. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134(10), 968–977. doi:10.7326/0003-4819-134-10-200105150-00011
   PubMed Web of Science ®Google Scholar
• Malta, M., Strathdee, S. A., Magnanini, M. M., & Bastos, F. I. (2008). Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: A systematic review. Addiction, 103(8), 1242–1257. doi:10.1111/j.1360-0443.2008.02269.x
   PubMed Web of Science ®Google Scholar
• Moore, D. J., Blackstone, K., Woods, S. P., Ellis, R. J., Atkinson, J. H., Heaton, R. K., & Grant, I. (2012). Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care, 24, 1504–1513. doi:10.1080/09540121.2012.672718
   PubMed Web of Science ®Google Scholar
• Osborn, C. Y., Paasche-Orlow, M. K., Davis, T. C., & Wolf, M. S. (2007). Health literacy: An overlooked factor in understanding HIV health disparities. American Journal of Preventive Medicine, 33(5), 374–378. doi:10.1016/j.amepre.2007.07.022
   PubMed Web of Science ®Google Scholar
• Paul, R. H., Brickman, A. M., Navia, B., Hinkin, C., Malloy, P. F., Jefferson, A. L., … Flanigan, T. P. (2005). Apathy is associated with volume of the nucleus accumbens in patients infected with HIV. Journal of Neuropsychiatry and Clinical Neurosciences, 17(2), 167–171. doi:10.1176/appi.neuropsych.17.2.167
   PubMed Web of Science ®Google Scholar
• R Development Core Team. (2010). R: A language and environment for statistical computing. (3-900051-07-0). Retrieved from http://www.R-project.org
   Google Scholar
• Siegel, K., Karus, D., & Schrimshaw, E. W. (2000). Racial differences in attitudes toward protease inhibitors among older HIV-infected men. AIDS care, 12, 423–434. doi:10.1080/09540120050123828
   PubMed Web of Science ®Google Scholar
• Simoni, J. M., Huh, D., Wilson, I. B., Shen, J., Goggin, K., Reynolds, N. R., … Liu, H. (2012). Racial/ethnic disparities in ART adherence in the United States: Findings from the MACH14 study. Journal of Acquired Immune Deficiency Syndrome, 60(5), 466–472. doi:10.1097/QAI.0b013e31825db0bd
   PubMed Web of Science ®Google Scholar
• Spitzer, R. L., Williams, J. B., Gibbon, M., & First, M. B. (1992). The structured clinical interview for DSM-III-R (SCID) I: History, rationale, and description. Archives of General Psychiatry, 49(8), 624–629. doi:10.1001/archpsyc.1992.01820080032005
   PubMed Web of Science ®Google Scholar
• Springer, S. A., Dushaj, A., & Azar, M. M. (2012). The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: A systematic review. AIDS and Behavior, 16(8), 2119–2143. doi:10.1007/s10461-012-0212-3
   PubMed Web of Science ®Google Scholar
• Thames, A. D., Moizel, J., Panos, S. E., Patel, S. M., Byrd, D. A., Myers, H. F., … Hinkin, C. H. (2012). Differential predictors of medication adherence in HIV: Findings from a sample of African American and Caucasian HIV-positive drug-using adults. AIDS Patient Care STDS, 26(10), 621–630. doi:10.1089/apc.2012.0157
   PubMed Web of Science ®Google Scholar
• Turner, B. J., Laine, C., Cosler, L., & Hauck, W. W. (2003). Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. Journal of General Internal Medicine, 18(4), 248–257. doi:10.1046/j.1525-1497.2003.20122.x
   PubMed Web of Science ®Google Scholar
• Wickham, H. (2007). Reshaping data with the reshape package. Journal of Statistical Software, 21(12), 1–20. Retrieved from http://www.jstatsoft.org/v21/i12/paper
   Web of Science ®Google Scholar